Dr Reddy’s Laboratories to Introduce Molnupiravir to Treat Covid-19 Shortly
Earlier this year, the drug major entered into a non-exclusive voluntary licensing agreement with Merck Sharpe Dohme (MSD) to manufacture and supply Molnupiravir to India and over 100 low and middle-income countries (LMICs). (File…